HF
CRMD icon

HRT Financial’s CorMedix CRMD Stock Holding History

HRT Financial’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.91M Buy
625,558
+333,113
+114% +$2.63M 0.01% 1163
2026
Q1 		$1.99M Buy
+292,445
New +$2.16M 0.01% 1624
2025
Q4 		– Sell
-43,840
Closed -$509K – 3297
2025
Q3 		$509K Sell
43,840
-13,203
-23% -$160K ﹤0.01% 1887
2025
Q2 		$702K Buy
+57,043
New +$630K ﹤0.01% 1435
2024
Q2 		– Sell
-13,721
Closed -$58K – 2353
2024
Q1 		$58K Buy
+13,721
New +$47.6K ﹤0.01% 1919

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

HRT Financial's CRMD Position: Q2 2026 in Review

HRT Financial increased its CorMedix (CRMD) stake by 114% in Q2 2026, buying an estimated $2.63M and bringing the position to 625,558 shares worth $4.91M. The position accounts for 0.01% of the portfolio, ranked #1163.

HRT Financial first reported a position in CRMD in Q1 2024 and has held it in 5 quarters since. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • HRT Financial held 625,558 shares of CorMedix worth $4.91M as of Q2 2026.
  • HRT Financial bought 333,113 CorMedix shares in Q2 2026, an estimated $2.63M.
  • CorMedix made up 0.01% of HRT Financial's portfolio in Q2 2026, its #1163 holding.
  • HRT Financial first reported a position in CorMedix in Q1 2024 and has held it in 5 quarters since.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.